Narayan Prabhu
2021
In 2021, Narayan Prabhu earned a total compensation of $437.1K as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 865% increase compared to previous year.
Compensation breakdown
| Option Awards | $162,134 |
|---|---|
| Salary | $275,000 |
| Total | $437,134 |
Prabhu received $275K in salary, accounting for 63% of the total pay in 2021.
Prabhu also received $162.1K in option awards.
Rankings
In 2021, Narayan Prabhu's compensation ranked 10,996th out of 12,406 executives tracked by ExecPay. In other words, Prabhu earned more than 11.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,996 out of 12,406 | 11th |
Division Manufacturing | 4,845 out of 5,492 | 12th |
Major group Chemicals And Allied Products | 2,165 out of 2,368 | 9th |
Industry group Drugs | 1,926 out of 2,089 | 8th |
Industry Pharmaceutical Preparations | 1,422 out of 1,536 | 7th |
Source: SEC filing on October 11, 2022.
Prabhu's colleagues
We found two more compensation records of executives who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2021.